Description
SEPTEMBER 2012 PAYMENT OF INVOICES.
First action · last action
2012-09-25 · 2013-04-15
Transactions
2
First transaction's obligation
$15,000
Base + all options value (sum of deltas)
$18,073
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-09-25+$15,000= $15,000
- Mod P000012013-04-15+$3,073= $18,073
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-09-25 | +$15,000 | $15,000 | SEPTEMBER 2012 PAYMENT OF INVOICES. |
| Mod P00001· FUNDING ONLY ACTION | 2013-04-15 | +$3,073 | $18,073 | SEPTEMBER 2012 PAYMENT OF INVOICES. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI TW6QHN8LNFH5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA26213P2377 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $487,727 | FY2013 |
| VA26212P0190 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $198,232 | FY2012 |
| VA25012P1200 | 552-DAYTON · 6505 · DRUGS AND BIOLOGICALS | $67,000 | FY2012 |
| VA26212P2526 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $68,000 | FY2012 |
| VA26212P2525 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $129,624 | FY2012 |
| VA26212P2524 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $63,291 | FY2012 |
Other recipients under 6505 from 552-DAYTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25013F1300 | SEQIRUS USA INC | 552-DAYTON | $81,750 | FY2013 |
| VA25013F0095 | CEPHEID | 552-DAYTON | $137,376 | FY2013 |
| VA25012P1348 | TRIAD ISOTOPES, INC. | 552-DAYTON | $6,359 | FY2012 |
| VA25012P1209 | MCKESSON PLASMA AND BIOLOGICS LLC | 552-DAYTON | $22,662 | FY2012 |
| VA25012P3160 | TRIAD ISOTOPES, INC. | 552-DAYTON | $12,000 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25012P1354_3600_-NONE-_-NONE- · retrieved 2026-09-26.